XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net loss $ (4,930) $ (5,261) $ (15,375) $ (15,475)
Other comprehensive gain (loss):        
Available for sale securities - net unrealized gain 12 0 3 1
Cumulative translation adjustment arising during the period 33 (50) 7 (72)
Total other comprehensive gain (loss) 45 (50) 10 (71)
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders $ (4,885) $ (5,311) $ (15,365) $ (15,546)